Biopharmaceuticals are one of the fastest growing areas in the pharmaceutical industry.Drugs made by isolation and extraction from microorganisms or plant and animal cells are often used to treat rheumatoid arthritis, cancer, diabetes and many other diseases.Biological agents are administered by injection To treat the human body, patients often need to go to the medical facilities to seek help or painful self-injection.
To address these challenges, Enable Injections has developed a disposable drug delivery device for the human body that enables patients to comfortably apply their own high-volume and / or high-viscosity therapeutic agents. The Enable device components are manufactured by Covestro, LLC Of polycarbonate material for injection molding.
The delivery unit is characterized by a purple shell made of Makroon® Rx 1805 polycarbonate.The white Bayblend® M850 XF PC + ABS blend plays an important role in the delivery system allowing patients to easily transfer biopharmaceuticals from their original container to Enable Conveyor.
Brian Faul, Business Development Manager for Polycarbonate at Midus, LLC, a division of Covestro LLC, said: 'Every step of the way in which Enables Injection is backed by the selection of the right polycarbonate to support in-house testing and production.'
Makrolon ® RX1805 polycarbonate is a medical grade resin commonly used in the manufacture of transparent parts for medical devices and offers the following benefits for the device enclosure including:
- Can be sterilized by high energy radiation
- Biocompatible, meets several requirements of the ISO 10993-1 test
-high viscosity
High lipid resistance
The Bayblend® M850 XF PC + ABS blend offers the following advantages for the delivery system, including:
- Biocompatible, meets several requirements of the ISO 10993-1 test
- Good liquidity
- Heat resistance up to 131 ° C (Vicat B / 120)
- High dimensional accuracy, high stability and high toughness
Lauren Zetts, North American Marketing Manager for Polycarbonate's Healthcare and Consumer Business at Covestro LLC, said: 'Biopharmaceuticals are very sensitive and choosing the right materials for the delivery system is critical to patient safety. "It is natural for the OEMs in the medical industry to provide the materials they need to bring their products to market, and we are naturally pleased that the company is selected for this application, which will also have a significant positive impact on the patient's life."
At the MD & M Western Conference and Exposition in Anaheim, California on February 6-8, attendees will be able to learn more about companies in the field of medical applications and materials by visiting Covestro booth # 2221 information.